iShares Global Healthcare ETF
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.
Profit Margin
| Q1 2013 | 4.27M | 44.63M | 1043.32% |
|---|---|---|---|
| Q2 2013 | 4.13M | 35.05M | 848.3% |
| Q3 2013 | 4.13M | 35.05M | 848.3% |
| Q4 2013 | 5.87M | 69.53M | 1184.01% |
IXJ Income Statement (Q1 2013 – Q4 2013)
| Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 5.87M | 4.13M | 4.13M | 4.27M |
Cost of revenue | 0 | 0 | 0 | 0 |
Gross profit | 5.87M | 4.13M | 4.13M | 4.27M |
Operating exp. | ||||
Research and development | 0 | 0 | 0 | 0 |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 63.66M | 30.92M | 30.92M | 40.35M |
Operating income | 4.66M | 3.14M | 3.14M | 3.53M |
Other income (expenses), net | 64.86M | 31.91M | 31.91M | 41.09M |
Income before tax | 69.53M | 35.05M | 35.05M | 44.63M |
Income tax expense | 64.86M | 31.91M | 31.91M | 41.09M |
Net income | 69.53M | 35.05M | 35.05M | 44.63M |
Earnings per share | ||||
Basic EPS | 2.78 | 1.57 | 1.57 | 2.22 |
Diluted EPS | 2.78 | 1.57 | 1.57 | 2.22 |